Gabriela Chiritoiu, Ph.D.
Inhibition of N-glycan processing modulates the network of EDEM3 interactors., Biochemical and biophysical research communications, 486(4), 978-984, 2017Butnaru CM, Chiritoiu MB, Chiritoiu GN, Petrescu SM, Petrescu AJIF=2.559
N-glycosylation of the transient receptor potential melastatin 8 channel is altered in pancreatic cancer cells., Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 39(8), 1010428317720940, 2017Ulăreanu R, Chiriţoiu G, Cojocaru F, Deftu A, Ristoiu V, Stănică L, Mihăilescu DF, Cucu D
Laser deposition of poly(3-hydroxybutyric acid-co-3-hydroxyvaleric acid) - lysozyme microspheres based coatings with anti-microbial properties., International journal of pharmaceutics, 521(1-2), 184-195, 2017Grumezescu V, Holban AM, Sima LE, Chiritoiu MB, Chiritoiu GN, Grumezescu AM, Ivan L, Safciuc F, Antohe F, Florica C, Luculescu CR, Chifiriuc MC, Socol G
Epitope located N-glycans impair the MHC-I epitope generation and presentation., Electrophoresis, 37(11), 1448-60, 2016Chiritoiu GN, Jandus C, Munteanu CV, Ghenea S, Gannon PO, Romero P, Petrescu SMIF=2.744
Tyrosinase degradation is prevented when EDEM1 lacks the intrinsically disordered region., PloS one, 7(8), e42998, 2012Marin MB, Ghenea S, Spiridon LN, Chiritoiu GN, Petrescu AJ, Petrescu SM
Musculoskeletal disorders affect 1 in 7 people and fractures alone affect 1 in 50 people annually while 10% of bone injuries fail to heal. Our present proposal aims to test for the first time the potential of fibroblast growth factor-2 (FGF2), to be administered as a stimulatory drug to enhance bone regeneration.